Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain Gardner

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Pharmaceutics|July 30, 2025
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case StudyXian Pan, Cong Liu, Felix Stader, et al.
The AAPS Journal|February 12, 2025
Application of a Physiologically Based Pharmacokinetic Approach to Predict Tenofovir Pharmacokinetics During PregnancyKhaled Abduljalil, Mailys De Sousa Mendes, Farzaneh Salem, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 7, 2011
The Drug Metabolism Discussion Group in 2011Michael Hall, Kevin Brady, Iain Gardner, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 10, 2025
Modeling and Simulation Identifies Endocytosis Uptake Rate and Fraction Unbound as Important Predictors of Oligonucleotide PharmacokineticsFelix Stader, Abdallah Derbalah, Adriana Zyla, et al.
Molecular Pharmaceutics|May 20, 2020
Biopharmaceutic <i>In Vitro In Vivo</i> Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State ConditionsSumit Arora, Amita Pansari, Peter Kilford, et al.
Clinical Pharmacology and Therapeutics|April 12, 2018
Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling ApproachUdoamaka Ezuruike, Helen Humphries, Maurice Dickins, et al.
Seminars in Nephrology|March 5, 2019
Modeling Exposure to Understand and Predict Kidney InjuryZhenhong Li, Ciaran Fisher, Iain Gardner, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Development and Verification of Virtual Population Models for Predicting Drug Pharmacokinetics in Ethnic North American PopulationsUdoamaka Ezuruike, Jean Dinh, Eman El-Khateeb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2007
Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonistsAlison Betts, Fidelma Atkinson, Iain Gardner, et al.
Mabs|April 14, 2025
The physiological limits of bispecific monoclonal antibody tissue targeting specificityArmin Sepp, Felix Stader, Abdallah Derbalah, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Pharmaceutics|July 30, 2025
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case StudyXian Pan, Cong Liu, Felix Stader, et al.
The AAPS Journal|February 12, 2025
Application of a Physiologically Based Pharmacokinetic Approach to Predict Tenofovir Pharmacokinetics During PregnancyKhaled Abduljalil, Mailys De Sousa Mendes, Farzaneh Salem, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 7, 2011
The Drug Metabolism Discussion Group in 2011Michael Hall, Kevin Brady, Iain Gardner, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 10, 2025
Modeling and Simulation Identifies Endocytosis Uptake Rate and Fraction Unbound as Important Predictors of Oligonucleotide PharmacokineticsFelix Stader, Abdallah Derbalah, Adriana Zyla, et al.
Molecular Pharmaceutics|May 20, 2020
Biopharmaceutic <i>In Vitro In Vivo</i> Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State ConditionsSumit Arora, Amita Pansari, Peter Kilford, et al.
Clinical Pharmacology and Therapeutics|April 12, 2018
Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling ApproachUdoamaka Ezuruike, Helen Humphries, Maurice Dickins, et al.
Seminars in Nephrology|March 5, 2019
Modeling Exposure to Understand and Predict Kidney InjuryZhenhong Li, Ciaran Fisher, Iain Gardner, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Development and Verification of Virtual Population Models for Predicting Drug Pharmacokinetics in Ethnic North American PopulationsUdoamaka Ezuruike, Jean Dinh, Eman El-Khateeb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2007
Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonistsAlison Betts, Fidelma Atkinson, Iain Gardner, et al.
Mabs|April 14, 2025
The physiological limits of bispecific monoclonal antibody tissue targeting specificityArmin Sepp, Felix Stader, Abdallah Derbalah, et al.
Pageof 11